本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Sutro Biopharma Inc

22.05
+0.72003.38%
成交量:5.22萬
成交額:115.88萬
市值:3.61億
市盈率:-0.85
高:23.25
開:23.21
低:21.09
收:21.33
52周最高:26.54
52周最低:5.23
股本:1,638.78萬
流通股本:1,388.51萬
量比:1.35
換手率:0.38%
股息:- -
股息率:- -
每股收益(TTM):-25.8759
每股收益(LYR):-29.6061
淨資產收益率:-1810.01%
總資產收益率:-25.80%
市淨率:-4.14
市盈率(LYR):-0.74

資料載入中...

2025/03/13

重要事件披露

Form 8-K - Current report
2025/02/27

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/12/10

重要事件披露

Form 8-K - Current report
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

重要事件披露

Form 8-K - Current report
2024/11/12

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/04

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/08/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/13

重要事件披露

Form 8-K - Current report
2024/08/12

重要事件披露

Form 8-K - Current report
2024/06/10

重要事件披露

Form 8-K - Current report
2024/05/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/13

重要事件披露

Form 8-K - Current report
2024/04/05

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/04/02

重要事件披露

Form 8-K - Current report
2024/04/02

重要事件披露

Form 8-K - Current report
2024/03/25

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]